A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2011
10/12/2011	CN102210651A Nitrofurazone washing fluid, preparation method and application thereof
10/12/2011	CN102210650A Prednicarbate emulsifiable paste and preparation method thereof
10/12/2011	CN102210649A Amphotericin B cream and preparation method thereof
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN102210647A Gel sustained-release preparation capable of improving ring-close rates of camptothecin and derivative lactone ring thereof
10/12/2011	CN102210646A Human rabies vaccine gel and preparation method thereof
10/12/2011	CN102210645A Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof
10/12/2011	CN102210630A System and method for preparing nosiheptide premix particles
10/12/2011	CN102210479A Novel method for preparing powder and particle product
10/12/2011	CN101947213B Method for preparing microcapsules from peptidoglycan in lactic acid bacterial cell walls
10/12/2011	CN101879281B Formula of honey refined gum for treating chloasma and preparation method thereof
10/12/2011	CN101850093B Medicinal composition for treating hyperplasia of mammary glands
10/12/2011	CN101829263B Traditional Chinese medicinal composition for treating redness and preparation thereof
10/12/2011	CN101822741B Oral ulcer healing membrane with traditional Chinese medicine bioadhesive one-way medicine release
10/12/2011	CN101810595B Preparation method of calcium alginate microcapsule
10/12/2011	CN101792444B Sodium levofolinate and preparation method and drug combination thereof
10/12/2011	CN101773512B 8-amino acid/11-vitamin containing micro granule capsule and preparation method thereof
10/12/2011	CN101732262B Method for preparing freeze-drying particle preparation for injection
10/12/2011	CN101721368B Medicinal composition for aerosol
10/12/2011	CN101717384B Compound in salvia miltiorrhiza bungered sage root injection and application thereof in curing treating cardiovascular disease
10/12/2011	CN101695558B Traditional Chinese medicinal composition for treating traumatic injury and rheumatism paralysis and preparation method thereof
10/12/2011	CN101693011B Preparation method of magnetic medicine-carrying nano-particle
10/12/2011	CN101658625B Hardness-softening antiphlogistine
10/12/2011	CN101618129B Chinese medical preparation for treating rheumatoid osteopathia
10/12/2011	CN101590031B preparation method of disodium sulfodehydroabietate (DSDA) and composition
10/12/2011	CN101575582B Lactobacillus separation strains with anti-inflammatory activity and application thereof
10/12/2011	CN101569608B Oral solid lipid nano-particle preparation of calcitonin and preparation method thereof
10/12/2011	CN101559120B Traditional Chinese medicinal ointment for treating radioepidermitis
10/12/2011	CN101524473B Worm grass anticancer longevity pellet and preparation method thereof
10/12/2011	CN101496808B Compound xanthophyll microcapsule for sight protection and preparation method thereof
10/12/2011	CN101396358B Oxiracetam injection
10/12/2011	CN101390987B Cataplasma for treating anti-motility fatigue and preparation method thereof
10/12/2011	CN101313959B Plaster medicament for treating scabies
10/12/2011	CN101306169B Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease
10/12/2011	CN101199847B Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof
10/12/2011	CN101199822B Capsule medicament for treating qi blood estrangement vitiligo
10/12/2011	CN101195013B Snuffing medicament for treating cold toothache
10/12/2011	CN101185704B Powder agent medicine for treating aphtha
10/12/2011	CN101185691B Powder agent medicine for treating infantile aphtha
10/12/2011	CN101185683B Cream shape medicine for treating infantile sweatful symptoms
10/12/2011	CN101116733B Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis
10/12/2011	CN101002765B Compressed formed preparation
10/11/2011	US8036748 Ingestible therapy activator system and method
10/11/2011	US8034845 administering to animals antibiotic deriavtives such as florfenicol or flunixin, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/11/2011	US8034817 Inhalation of quinolinonecarboxylic acid compound
10/11/2011	US8034450 Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
10/11/2011	US8034395 Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof
10/11/2011	US8034385 Anti-ageing skin cosmetic
10/11/2011	US8034383 Injectable microspheres
10/11/2011	US8034382 Preparation method for biodegradable micro-particles containing drugs
10/11/2011	US8034381 Method for producing ultrafine submicronic suspensions
10/11/2011	US8034380 Immediate release pharmaceutical tablets with height greater than width
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034378 water; a biodegradable microparticle of a polylactone, polyorthoester, a polyanhydride, or a polycyanoacrylate; an antigen adsorbed to the microparticle; and a phospholipid adjuvant with one or more phosphoric acid or phosphodiester groups and linear alkane groups
10/11/2011	US8034377 DHA esters and use thereof in treatment and prevention of cardiovascular disease
10/11/2011	US8034376 Lipid containing formulations
10/11/2011	US8034375 Combinations and modes of administration of therapeutic agents and combination therapy
10/11/2011	US8034374 Patch containing nonsteroidal anti-inflammatory and analgesic agent
10/11/2011	US8034371 Intranasal compositions
10/11/2011	US8034370 Active agent dispersed within a biodegradable polymer matrix; bioerodible
10/11/2011	US8034369 Controlled release bioactive agent delivery device
10/11/2011	US8034366 Poly lactic co-glycolic acid copolymer biodegradable polymer matrix; eye implant infused with ace-inhibitors, endogenous cytokines, agents that influence basement membrane, agents that influence the growth of endothelial cells, adrenergic agonists or blockers; uveitis, macular edema, macular degeneration
10/11/2011	US8034364 Implantable medical device comprising a pro-healing(ester-amide)
10/11/2011	US8034363 Sustained release systems of ascorbic acid phosphate
10/11/2011	US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	US8034325 Powder formed of particles of biliquid foam entrapped within polymeric matrix
10/11/2011	US8034324 styling composition comprising a silicone pressure sensitive adhesive comprising a silicone resin and a polydiorganosiloxane; comprises less than 0.5 wt % of water; decrease the drying time of hair
10/11/2011	US8034048 Tissue patches and related delivery systems and methods
10/11/2011	CA2727735C Disinfectant and/or bactericidal aqueous compositions
10/11/2011	CA2553413C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
10/11/2011	CA2536977C Non-polar photosensitizer formulations for photodynamic therapy
10/11/2011	CA2529491C Hot liquid fiber product
10/11/2011	CA2520523C Oral formulations of cladribine
10/11/2011	CA2506930C Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
10/11/2011	CA2464578C Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
10/11/2011	CA2464322C Methods of treatment using a gastric retained gabapentin dosage
10/11/2011	CA2457124C Topical composition, topical composition precursor, and methods for manufacturing and using
10/11/2011	CA2457027C Chitin microparticles and their medical uses
10/11/2011	CA2456180C Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct)
10/11/2011	CA2454665C Modifying the fatty acid composition of cell membranes of organs and tissues
10/11/2011	CA2447663C Composition and use of substances for the stabilization of sulphur-containing amino acids
10/11/2011	CA2442151C Stable solution of reduced coenzyme q
10/11/2011	CA2438116C Amphoteric liposomes and the use thereof
10/11/2011	CA2429674C Generation of therapeutic microfoam
10/11/2011	CA2424734C Nanoparticles comprising a metallic or semiconductor core which is covalently bound to a plurality of carbohydrate ligands
10/11/2011	CA2402773C Tissue bulking and coating compositions
10/11/2011	CA2400482C Bupropion metabolites and methods of their synthesis and use
10/11/2011	CA2382177C Method of treating body insect infestation
10/11/2011	CA2242107C Multilayer tablet
10/11/2011	CA2237578E Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
10/07/2011	CA2736448A1 Polyamide 1010 powder and its use in personal care products
10/06/2011	WO2011123866A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/06/2011	WO2011123836A2 Pharmaceutical formulations for the treatment of overactive bladder
10/06/2011	WO2011123619A2 Permeable mixtures, methods and compositions for the skin
10/06/2011	WO2011123525A1 Forming an artificial cell with controlled membrane composition, asymmetry and contents
10/06/2011	WO2011123497A1 Stabilized formulations of cns compounds
10/06/2011	WO2011123416A1 Injectable drug delivery formulation
10/06/2011	WO2011123395A1 Methods of treating cancer

1 ... 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 ... 2991